Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine

Clin Infect Dis. 2021 Sep 15;73(6):e1402-e1403. doi: 10.1093/cid/ciab214.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • Immunoglobulin G
  • RNA, Messenger
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • Immunoglobulin G
  • RNA, Messenger
  • BNT162 Vaccine